Article | December 9, 2013

Real/Future Information Risk of R&D – CROs

Source: Life Science Leader

The jury is still out on the ultimate impact of healthcare reform in general, and perhaps this impact is even murkier in the life sciences  space.  Certainly there will be very dramatic changes to the providers (hospitals, primary care, etc.) and payers (insurance companies, health plans, etc.), but it is more difficult to see exactly how the changes will manifest themselves for the remaining entities in the health sciences arena.